Infinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosedMG
Merck Global Health Innovation Fund
Activity from announced rounds
Activity in this selectionkorea-investment-partners-dbedb086
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $75M 1 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionDropGenie
Miniaturizes gene editing workflows to enable direct edits on primary patient cells for cell therapy and drug discovery
UndisclosedSeed+
Role not disclosed